NEWS

PRESS RELEASE

Vesalio Expands Sales Network, Initiates Virtual Physician Training and...

Vesalio announces it has executed additional exclusive distribution agreements in Europe, Latin America, Asia, and the Middle East. With these new partnerships, the NeVa™ Thrombectomy System has gained market coverage in 53 countries.

PRESS RELEASE

Wallaby Medical Raises over $20M in Series B+ Financing to Accelerate De...

The new funding will promote the development of a global hemorrhagic and ischemic stroke treatment product portfolio, as well as support the company’s two ongoing clinical trials.

PRESS RELEASE

Cerus Endovascular and Balt Enter Strategic Distribution Agreement for I...

FREMONT, Calif. and OXFORD, United Kingdom and MONTMORENCY, France, Cerus Endovascular Ltd., a privately-held, commercial-stage medical device company and AB Medica Deutschland Verwaltungs GmbH, a wholly owned subsidiary of Balt, today announced that they have entered into a strategic distribution agreement providing AB Medica with the exclusive rights to market and sell the newly CE marked Contour Neurovascular System™ and the Neqstent Coil Assisted Flow Diverter devices in Germany. Terms of the agreement were not disclosed.

PRESS RELEASE

Cerus Endovascular Receives CE Mark Approval for its CerusEndo MC 021 Mi...

Commercial Sales Across European Union Expected to Begin During Fourth Quarter of 2020

PRESS RELEASE

European launch of NEW pRESET 5-40 & pRESET LUX thrombectomy devices

Phenox today announced the full European launch of the pRESET 5-40 and pRESET LUX 4-20 thrombectomy devices after receiving CE mark approval last year.

PRESS RELEASE

Granted reimbursement of the Silk+ flow diverter on the French market

Balt is thrilled to announce today, the Silk+ reimbursement has been granted on the French market.

PRESS RELEASE

Device performance evaluated: extensive in vitro testing of the CascadeT...

The CascadeTM Non-Occlusive Remodeling Net (Perflow Medical, Israel) is an innovative fully retrievable neck-bridging temporary support device designed for use during coil embolisation of intracranial aneurysms which allows for flow within the parent vessel while providing coverage at the neck during coiling of the aneurysm. In this article, the Cascade device was tested in vitro within a variety of aneurysm types and – after 480 attempted coilings – no evidence of coil protrusion either through the mesh wall of the device itself or any coil protrusion into the parent vessel was observed,underlining device viability and effectiveness.

PRESS RELEASE

Phenox GmbH launches p64 MW Flow Modulation Device with HPC coating tech...

Bochum, Germany – 27 April 2020 - Phenox GmbH, a pioneer of innovative technologies for neurovascular diseases, has announced the European launch of the new p64 MW Flow Modulation Device. The device received CE mark in January 2020 and is available with the proprietary HPC surface modification, a new technology which could revolutionize patient care in vascular intervention. 

PRESS RELEASE

Cerus Endovascular Receives CE Mark Approval for its 021 Contour Neurova...

FREMONT, Calif. and OXFORD, England, April 29, 2020 /PRNewswire/ -- Cerus Endovascular Ltd., a privately-held, commercial stage medical device company, today announced that it has received CE Mark approval for its 021 Contour Neurovascular System™, compatible with smaller commercially available 021 microcatheters for the treatment of saccular intracranial aneurysms. The Contour Neurovascular System™ is a unique, fine mesh braid that is deployed across the neck of the aneurysm sac and provides a combination of flow diversion and flow disruption through a single device implant. This new, lower profile system will allow physicians to access more distally challenging vascular anatomies.

PRESS RELEASE

Cerus Endovascular Receives CE Mark Approvals for its Neqstent™ Coil Ass...

Fremont, California and Oxford, United Kingdom April 22, 2020 – Cerus Endovascular Ltd., a privately-held, commercial stage medical device company, today announced that it has received CE Mark approval for its Neqstent™  Coil Assisted Flow Diverter device, designed to treat intracranial aneurysms. Neqstent™ is designed to treat a range of aneurysm morphologies including wide-necked bifurcation and bifurcation aneurysms. Neqstent™ is an adjunctive intrasaccular flow diverter device that provides stable aneurysm neck coverage for the placement of embolization coils within the sac and long-term occlusion of the aneurysm.